• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000252
Device Problems Fluid/Blood Leak (1250); Off-Label Use (1494); Material Rupture (1546)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/04/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).See mdr #3010532612-2019-00457 and (b)(4) for complaint involving the same patient and event.
 
Event Description
It was reported by the rn that blood was noted in the driveline tubing.The rn called the hotline and spoke to the clinical support specialist (css) and reported that there was blood in the current tubing.The patient was received from an outside hospital.The css explained that the blood in the tubing meant that there was a balloon rupture and the balloon needed to be removed.The rn stated that the physicians did not want to change out the intra-aortic balloon (iab).The iab was not inserted through the femoral artery.The css explained the possible complications if they continue to use the iab.The nurse stated that she would contact the physician.The css received another call from the facility, this time it was the fellow.He wanted assistance in switching the gas drive line tubing over to the maquet intra-aortic balloon pump (iabp).The css discussed with the dr.That if the iab was left in place that it could result in difficulties with removal and complications to the patient.The dr.Is aware of the possible complications to the patient but did not want to change out the catheter.The css explained how to change the gas drive tubing to the maquet pump.The iab was inserted off label.There was no report of injury or consequence to the patient.
 
Manufacturer Narrative
(b)(4).Teleflex did not receive the device for investigation therefore the reported complaint of iab blood in helium pathway is not able to be confirmed.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risks.The reported complaint will be monitored for any developing trends.No further action required at this time.Other remarks: see mdr #3010532612-2019-00457 and tc # (b)(4), mdr #3010532612-2019-00435 and tc # (b)(4) for complaint involving the same patient and event.
 
Event Description
It was reported by the rn that blood was noted in the driveline tubing.The rn called the hotline and spoke to the clinical support specialist (css) and reported that there was blood in the current tubing.The patient was received from an outside hospital.The css explained that the blood in the tubing meant that there was a balloon rupture and the balloon needed to be removed.The rn stated that the physicians did not want to change out the intra-aortic balloon (iab).The iab was not inserted through the femoral artery.The css explained the possible complications if they continue to use the iab.The nurse stated that she would contact the physician.The css received another call from the facility, this time it was the fellow.He wanted assistance in switching the gas drive line tubing over to the maquet intra-aortic balloon pump (iabp).The css discussed with the dr.That if the iab was left in place that it could result in difficulties with removal and complications to the patient.The dr.Is aware of the possible complications to the patient but did not want to change out the catheter.The css explained how to change the gas drive tubing to the maquet pump.The iab was inserted off label.There was no report of injury or consequence to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 30CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key9526880
MDR Text Key183768271
Report Number3010532612-2019-00455
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902034724
UDI-Public00801902034724
Combination Product (y/n)N
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model NumberIPN000252
Device Catalogue NumberIAB-05830-LWS
Device Lot Number18F18L0001
Was Device Available for Evaluation? No
Date Manufacturer Received01/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-